SOLV

HOLD

Solventum Corporation

Healthcare · Rank #13 · Analyzed Oct 18, 2026

$85.81

Current Price

$157.40

Intrinsic Value

+83.4%

Upside/Downside

7.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score2.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 83.4%

Fair Value Range

Low$78.70

Base (IV)$157.40

High$204.62

Entry Points

Conservative$55.09

Moderate$78.70

Aggressive$110.18

Quality & Moat Breakdown

Return on Equity34.0% → 1.0/1.0

Debt LevelD/E 110 → 0/1.0

Revenue QualityGrowth 5.8%, margin Δ-10.6% → 0.5/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins17.3% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.